Farmabase | CYDEX®

CYDEX® es un producto a base de ciromacina, un potente larvicida dirigido al control de las moscas en los sitios de producción. Entre sus características, se destacan: • Mayor concentración; • Larvicida de alta eficacia; • Flexibilidad de uso: vía alimento o pulverización; • Control eficiente de las moscas en la producción de ...

CYDEX-B GC Columns

Product specifications. Permethylated Beta-Cyclodextrin (Chiral). Suitable replacement for: Cyclodex-B, Rt-BDEXm, LIPODEX C. Film thickness. Operating temperature. 0.25 µm. 30°C to 220/240°C.

нунтаглалт

Нунтаглагч биетийн хорогдлыг: G=Gб*e-k*t D=Dб* e-k*t Gб,Dб -анхны бөөрөнцгүүдийн жин диамет G, D-t хугацааны дараах бөөрөнцгүүдийн жин диаметр

Sulfobutylether-β-cyclodextrin

Later, in work done by our collaborators and co-developers, Pfizer and CyDex (more later), synthetic scaling and better analytical tools for determining remaining unreacted β-cyclodextrin in samples, it was agreed that SBE 6.5-β-CD was the preferred derivative (Stella and He, 2008, Luke et al., 2010).

CyDex Pharmaceuticals, Inc.

Docket for CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA, 1:19-cv-00956 — Brought to you by the RECAP Initiative and Free Law Project, a non-profit dedicated to creating high quality open legal information.

CyDex Pharmaceuticals, Inc.

CyDex Pharmaceuticals, Inc. is a privately held, specialty pharmaceutical company developing products and licensing its CAPTISOL enabling technology. CyDex is developing its own pipeline of products using its enabling technology solutions, and partnering with leading pharmaceutical, specialty pharmaceutical and biotechnology companies. CyDex …

Farmabase | CYDEX®

CYDEX® é um produto à base de ciromazina, um potente larvicida direcionado para o controle das moscas nos locais de produção animal. Dentre suas características, destacam-se: • Maior concentração; • Larvicida de alta eficácia; • Flexibilidade de uso: via ração ou pulverização; • Controle eficiente de moscas na produção de ...

Captisol

Not all cyclodextrins are created equal. Captisol ® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of …

Captisol

Not all cyclodextrins are created equal. Captisol ® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly improving solubility, stability, bioavailability and dosing of insoluble ingredients. Get Free Sample Order Now Resources.

Captisol® and Nexterone® :: Captisol

In 2001, CyDex (now Ligand) began development of Amiodarone HCL, brand name Cordarone ® I.V. This work led to a Patent being granted in 2005 and in 2006, CyDex licensed Captisol to Prism. This work led to a Patent being granted in 2005 and in 2006, CyDex licensed Captisol to Prism.

нунтаглалт

Нунтаглагч биетийн хорогдлыг: G=Gб*e-k*t D=Dб* e-k*t Gб,Dб -анхны бөөрөнцгүүдийн жин диамет G, D-t хугацааны дараах бөөрөнцгүүдийн жин …

Captisol

Not all cyclodextrins are created equal. Captisol ® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly …

Solución CIDEX™ OPA | Advanced Sterilization Products

Descripción del Producto. La solución CIDEX ™ OPA es un desinfectante de alto nivel para reprocesar dispositivos médicos semicríticos sensibles al calor y reutilizables, como equipos endoscópicos, de terapia respiratoria y de anestesia. Efectivo: logra desinfección de alto nivel en 5 minutos a 20 °C (68 °F)

Cydex – Consultoria

En CYDEX Corporativo de Soluciones Empresariales estamos enfocados en acompañar y brindar las mejores soluciones prácticas en nuestros servicios de Consultoría, …

Cytodex 3 microcarriers (dry powder) | Cytiva

Microcarrier culture is a technique which makes possible the practical high yield culture of anchorage-dependent cells. Cytodex has been specifically developed for the culture of a wide range of animal cells in culture volumes ranging from a few ml to more than 6000 L. Using Cytodex in simple suspension culture systems provides yields of ...

Management Team :: Ligand Pharmaceuticals Incorporated (LGND)

He joined CyDex in 2005. Dr. Antle is currently responsible for quality assurance, internal drug product quality, operations, distribution and logistics for Captisol. From 1999 to 2005, Dr. Antle was Technical Operations Manager and Head of Process Development at EaglePicher Pharmaceuticals Services. Prior to 1999, he was Group Leader for the ...